Back to search

Company profile

NUCLEOTIDE MEDICAL LIMITED

active • ltd • C/O Aacsl Accountants Ltd, 1st Floor, North Westgate House, Harlow, Essex, CM20 1YS, United Kingdom

Company no.12381558Officers2Documents20

Key company facts

Core operating details surfaced from the public profile endpoint.

Company Number
12381558
Company Status
active
Type
ltd
Date Of Creation
2019-12-31
Registered Office
C/O Aacsl Accountants Ltd, 1st Floor, North Westgate House, Harlow, Essex, CM20 1YS, United Kingdom
Sic Codes
other human health activities

Financials

A cleaner view of the latest filing, balance sheet movement, and multi-year trend.

Total assets

£4,297

Equity

£100

Total liabilities

£4,197

Cash in bank

£0

Year-on-year movement

Quick comparison from the latest filed period.

2024-12-31

Equity

+£0.00

0.00%

Cash in bank

+£0.00

0%

Total assets

-£5.67k

-56.90%

Total liabilities

+£5.67k

+57.47%

Financial trend

Multi-year view of the main balance sheet lines.

Net Assets
Total Assets
Total Liabilities
2021202220232024

Latest snapshot

Financial year2024
Statement date2024-12-31
Trade debtors£0
Trade creditors£0
Fixed assets£0
Current assets£4,297
YearNet AssetsTotal AssetsTotal Liabilities
2021£1£20,835-£20,834
2022£100£20,209-£20,109
2023£100£9,969-£9,869
2024£100£4,297-£4,197

Available In The Full Platform

Unlock deeper company intelligence

More company intelligence is available through your account, including premium data, deeper records, and advanced insight.

Locked contact intelligence

Contact Details & Ownership

Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.

Locked insight

Sign up or log in to view contact insight

Contact DetailsShareholdersGroup StructureCorporate Network Graph

Locked compliance screening

Risk & Compliance

Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.

Locked insight

Sign up or log in to access compliance insight

KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register

Locked financial insight

Financial Intelligence

Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.

Locked insight

Sign up or log in to unlock financial insight

AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges

Locked filing intelligence

Assets, Filings & Registers

Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.

Locked insight

Sign up or log in to explore filing insight

PropertyTrademarkGazette NoticesCharges

Latest activity

Recent company and officer updates, reshaped from the watchlist activity source for public profile use.

UpdateDateRecency
Confirmation Statement Submitted8 May 20261 Month
Accounts Submitted26 Sep 20258 Months
Confirmation Statement Submitted8 May 20251 Year
Confirmation Statement Submitted28 Jan 20251 Year
OLOWONYO, Gbemisola Anne Appointed28 Jan 20251 Year
Accounts Submitted4 Sep 20241 Year
Accounts Submitted6 Jun 20242 Years
Confirmation Statement Submitted6 Jun 20242 Years
Change of Date Of Creation6 Jun 20242 Years
Change of Jurisdiction6 Jun 20242 Years
Change of Registered Office Address6 Jun 20242 Years
Change of Type6 Jun 20242 Years

Documents

Public filing documents and direct PDF links where available.

DescriptionDateDocument
confirmation-statement-with-no-updates2026-05-08Open PDF
accounts-with-accounts-type-micro-entity2025-09-26Open PDF
change-to-a-person-with-significant-control2025-05-08Open PDF
confirmation-statement-with-updates2025-05-08Open PDF
notification-of-a-person-with-significant-control2025-01-28Open PDF
change-to-a-person-with-significant-control2025-01-28Open PDF
confirmation-statement-with-updates2025-01-28Open PDF
appoint-person-director-company-with-name-date2025-01-28Open PDF
accounts-with-accounts-type-micro-entity2024-09-04Open PDF
confirmation-statement-with-updates2024-06-06Open PDF
change-to-a-person-with-significant-control2024-01-03Open PDF
change-person-director-company-with-change-date2024-01-03Open PDF